ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 256927 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 256927; 2) Community: the network communities that were significantly associated with the response to NSC 256927; 3) Molecule: the relationships between components within communities and NSC 256927; 4) MDR: the compounds that were significantly associated with the NSC 256927.

NSC Compound Enrichment Correlation
NSC 696661 (6R,6S)-2,4-Diamino-6-(3,4,5-trimethoxybenzyl)-5,6,7,8-tetrahydroquinazoline 0.00706774869341649 0.42948633
NSC 610744 Imidazole, 1-(4-chlorophenyl)-4-(4-nitrophenyl)- 0.00707875925191917 -0.064963915
NSC 625497 Antimony, dibromo(4-thiomorpholinecarbodithioato-S,S')-, (T-4)- 0.00707875925191917 0.62137425
NSC 658145 2-(2-(Dimethylamino)ethylamino)naphthazarin 0.00707875925191917 0.49741177
NSC 666783 Pyrido[2,3-d]pyrimidine-2,4-diamine, 6-[[(4-methoxy- phenyl)amino]methyl]-5-methyl-, 3/5 methanol 0.00707875925191917 0.52891415
NSC 681684 2-Trifluoroethoxy-6-oxoestra-1,3,5(10)-trien-3,17.beta.-diol 0.00707875925191917 0.44325878
NSC 681776 Null 0.00707875925191917 -0.28040657
NSC 688526 Null 0.00707875925191917 -0.11682425
NSC 174121 Methotrexate Derivative 0.00707875925191925 0.41191096
NSC 143241 Dibenzo[de,g]quinoline-6-carboxylic acid, 4,5-dihydro- 1,2,9,10-tetramethoxy-, ethyl ester 0.00838963112864931 0.39941151
Total:80  Current:10    [First] [Prev] [Next] [Last]